![Peter Kanekrans](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Kanekrans
Corporate Officer/Principal chez
Söderlind & Co. AB
Profil
Peter Kanekrans is currently a Principal at Söderlind & Co. AB since 1998.
Prior to this, he worked as a Project Manager-Corporate Finance at Carnegie Fond AB from 1987 to 1992 and at Göteborgs Enskilda Bank from 1984 to 1987.
He also served as the Head-Investor Relations at Dextech Medical AB.
Postes actifs de Peter Kanekrans
| Sociétés | Poste | Début |
|---|---|---|
Söderlind & Co. AB
 Söderlind & Co. AB Investment ManagersFinance Provides financial management and legal services | Corporate Officer/Principal | 01/01/1998 |
Anciens postes connus de Peter Kanekrans
| Sociétés | Poste | Fin |
|---|---|---|
Carnegie Fond AB
 Carnegie Fond AB Investment ManagersFinance CF is an active investment manager following a growth-oriented investment approach. They invest in global equity across all market-caps, complemented with fixed-income, with the bulk of their investments in Swedish and US equity. Research is both performed in-house and shared with other Carnegie divisions. The firm's investment process is research-driven and starts with the analysis of long-term global trends. Sector allocation is top-down and based on macro-economic analysis focusing on the global economic cycle, inflation rates and development, future interest rate levels, and FX prices. Within select sectors, bottom-up stock-picking targets companies with growth potential. Stock selection is based on in-depth financial analysis, focusing on financial soundness, cash-flow analysis, profitability, growth history, management experience and ability, market position, ownership structure and stock liquidity. Company visits are part of the research process, as are reports by local analysts. | Corporate Officer/Principal | 01/01/1992 |
Göteborgs Enskilda Bank
 Göteborgs Enskilda Bank Regional BanksFinance Provides commercial banking services | Corporate Officer/Principal | 01/01/1987 |
| DEXTECH MEDICAL AB | Investor Relations Contact | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Carnegie Fond AB
Carnegie Fond AB Investment ManagersFinance CF is an active investment manager following a growth-oriented investment approach. They invest in global equity across all market-caps, complemented with fixed-income, with the bulk of their investments in Swedish and US equity. Research is both performed in-house and shared with other Carnegie divisions. The firm's investment process is research-driven and starts with the analysis of long-term global trends. Sector allocation is top-down and based on macro-economic analysis focusing on the global economic cycle, inflation rates and development, future interest rate levels, and FX prices. Within select sectors, bottom-up stock-picking targets companies with growth potential. Stock selection is based on in-depth financial analysis, focusing on financial soundness, cash-flow analysis, profitability, growth history, management experience and ability, market position, ownership structure and stock liquidity. Company visits are part of the research process, as are reports by local analysts. | Finance |
Göteborgs Enskilda Bank
Göteborgs Enskilda Bank Regional BanksFinance Provides commercial banking services | Finance |
Söderlind & Co. AB
Söderlind & Co. AB Investment ManagersFinance Provides financial management and legal services | Finance |
Dextech Medical AB
 Dextech Medical AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of drug candidates for urologic oncology | Health Technology |
